MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.

Filiacions

Monteagudo M:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

PhD Program in Neuroscience, Universidad Autonoma de Madrid-Cajal Institute, Madrid, Spain

Calsina B:

Familial Cancer Clinical Unit, Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Salazar-Hidalgo ME:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Martínez-Montes ÁM:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Piñeiro-Yáñez E:

Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Caleiras E:

Histopathology Core Unit Biotechnology Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Martín MC:

Molecular Citogenetic Unit Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Rodríguez-Perales S:

Molecular Citogenetic Unit Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Letón R:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Gil E:

Familial Cancer Clinical Unit, Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Buffet A:

Département de médecine génomique des tumeurs et des cancers, AP-HP, Hôpital Européen Georges Pompidou, Paris, France

Université Paris Cité, Inserm, PARCC, Paris, France

Burnichon N:

Département de médecine génomique des tumeurs et des cancers, AP-HP, Hôpital Européen Georges Pompidou, Paris, France

Université Paris Cité, Inserm, PARCC, Paris, France

Fernández-Sanromán Á:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Díaz-Talavera A:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Centro De Investigación Biomédica En Red De Enfermedades Raras (CIBERER), Madrid, Spain

Mellid S:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Arroba E:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Reglero C:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Martínez-Puente N:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

PhD Program in Neuroscience, Universidad Autonoma de Madrid-Cajal Institute, Madrid, Spain

Roncador G:

Monoclonal Antibodies Core Unit Biotechnology Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Del Olmo MI:

Department of Endocrinology and Nutrition, University Hospital La Fe, Valencia, Spain

Corrales PJP:

Department of Endocrinology and Nutrition Albacete University Hospital, SESCAM, Albacete, Spain

Oliveira CL:

Department of Endocrinology and Nutrition Albacete University Hospital, SESCAM, Albacete, Spain

Álvarez-Escolá C:

Department of Endocrinology, La Paz University Hospital, Madrid, Spain

Gutiérrez MC:

Department of Endocrinology and Nutrition 12 de Octubre University Hospital, Madrid, Spain

López-Fernández A:

Department of Medical Oncology, Vall d'Hebrón Hospital, Barcelona, Spain

García NP:

Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain

Regojo RM:

Department of Pathology, La Paz University Hospital, Madrid, Spain

Díaz LR:

Department of Oncology, 12 de Octubre University Hospital, Madrid, Spain

Laorden NR:

Department of Medical Oncology, La Princesa University Hospital, Madrid, Spain

Guadarrama OS:

Department of General Surgery, University Hospital of León, León, Spain

Bechmann N:

Institute for Clinical Chemistry and Laboratory Medicine Faculty of Medicine and University Hospital Carl Gustav Carus Technische Universität Dresden, Dresden Germany, Germany

Beuschlein F:

Medizinische Klinik und Poliklinik IV Klinikum der Universität München, Munich, Germany

Klinik für Endokrinologie Diabetologie und Klinische Ernährung UniversitätsSpital Zürich, Zürich, Switzerland

LOOP Zurich - Medical Research Center, Zurich, Switzerland

Canu L:

Department of Experimental and Clinical Medicine University of Florence, Florence, Italy

Eisenhofer G:

Department of Medicine III University Hospital Carl Gustav Carus Technische Universität Dresden, Dresden, Germany

Fassnacht M:

Department of Internal Medicine I Division of Endocrinology and Diabetes University Hospital Würzburg University of Würzburg, Würzburg, Germany

Comprehensive Cancer Center Mainfranken University of Würzburg, Würzburg, Germany

Nölting S:

Klinik für Endokrinologie Diabetologie und Klinische Ernährung UniversitätsSpital Zürich, Zürich, Switzerland

Quinkler M:

Endocrinology in Charlottenburg Stuttgarter Platz 1, Berlin, Germany

Rapizzi E:

Department of Experimental and Clinical Medicine University of Florence, Florence, Italy

Remde H:

Comprehensive Cancer Center Mainfranken University of Würzburg, Würzburg, Germany

Favier J:

Département de médecine génomique des tumeurs et des cancers, AP-HP, Hôpital Européen Georges Pompidou, Paris, France

Université Paris Cité, Inserm, PARCC, Paris, France

Gimenez-Roqueplo AP:

Département de médecine génomique des tumeurs et des cancers, AP-HP, Hôpital Européen Georges Pompidou, Paris, France

Université Paris Cité, Inserm, PARCC, Paris, France

Rodriguez-Antona C:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Currás-Freixes M:

Familial Cancer Clinical Unit, Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Al-Shahrour F:

Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Cascón A:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Centro De Investigación Biomédica En Red De Enfermedades Raras (CIBERER), Madrid, Spain

Leandro-García LJ:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Montero-Conde C:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Centro De Investigación Biomédica En Red De Enfermedades Raras (CIBERER), Madrid, Spain

Robledo M:

Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Centro De Investigación Biomédica En Red De Enfermedades Raras (CIBERER), Madrid, Spain